Applied Biocode, Inc.

Applied Biocode, Inc.

Applied BioCode, Inc. develops, manufactures, and commercializes multiplex diagnostic testing products. The company's products focus on the $4.5 billion molecular diagnostic infectious disease segment of the market with assays that detect pathogens for gastrointestinal, respiratory, fungal, and sexually transmitted infections.

Infectious Disease Testing, Influenza Testing, Molecular Diagnostics, Multiplex Testing, STD Testing, Immunofluorescence, Immunoassay Systems, DNA/RNA Based Reagents, Immunoassay Diag/Reagents/Kits, Magnetic Particles

No

Licensing Agreements

United States